It has been reported that LOXL4 monoclonal antibody (LOXL4-mAb) effectively prevents the growth of head and neck squamous cell carcinoma (HNSCC) cells in vivo (39). The gene discussed is LOXL4; the disease is head and neck squamous cell carcinoma.